President, Preventive Oncology Int., Prof. Surgery Cleveland Clinic Lerner College of Medicine

Obstetrics & Gynecology

Jerome Belinson practices Obstetrics & Gynecology. He went to University of Missouri-Columbia School of Medicine. He received awards:"The John L Lewis Presidential Award, 45th Annual Meeting on Womens Cancer", "Friendship Award", "Chinese Friendship Award at the Peoples Congress in Beijing The Highest Award China gives to a Foreigner", "Awarded Best Presentation by a Fellow", "World Class Service Award for Patient Care, Department of Ob/GYN", "Citation of Merit, the highest given award, given annually to one alumnus to recognize that physician's contributions to the medical profession", "3rd, 60-Meter Dash", "Paul Harris Fellow (for work in Mexico)", "Cited by Ladies Home Journal as one of the Top Doctors for Women in the United States, one of 15 Gynecologic Oncologists in the Northeast (13 states)", "Teacher of the Year, Dept. Ob/Gyn", "1st Place Award ($5,000) Presentation at Eurogin", "Stewart Fellow (Humanitarianism in Medicine)", "3rd, Long Jump", "3rd Triple Jump", "1st, Long Jump", "Cited in The Best Doctors in America, Midwest Region, Naifeh and Smith, 1st Ed", "2nd, Long Jump", "Cited in The Best Doctors in America, Naifeh and Smith, 1st Ed", "Alpha Omega Alpha, Medical Honorary Society", "Teacher of the Year", "Certificate of Special Competence - Division of Gynecologic Oncology", "Fellow", "Fellow (FACOG)" and "Cited several years as top doctor". Jerome L. Belinson, MD is also published. He has 100 publications published. The lastest publication: "Influence of exploratory celiotomy on the management of carcinoma of the cervix. A preliminary report.' Jerome L. Belinson accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Evaluation of a new solid media specimen transport card for high risk HPV detection and cervical Cancer prevention.
• Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer.
• High-Grade Cervical Intraepithelial Neoplasia Detected by Colposcopy-Directed or Random Biopsy Relative to Age, Cytology, Human Papillomavirus 16, and Lesion Size.
• p16 Immunohistochemistry in Colposcope-Directed and Random Cervical Biopsies of CIN2 and CIN3.
• Mexican Cervical Cancer Screening Study II: 6-Month and 2-Year Follow-up of HR-HPV Women Treated With Cryotherapy in a Low-Resource Setting.
• Use of artemisinin and its derivatives to treat HPV-infected/transformed cells and cervical Cancer: a review.
• The development and evaluation of a community based model for cervical Cancer screening based on self-sampling.
• The Peru Cervical Cancer Screening Study (PERCAPS): The Design and Implementation of a Mother/Daughter Screen, Treat, and Vaccinate Program in the Peruvian Jungle.
• Yield and Mode of Diagnosis of Cervical Intraepithelial Neoplasia 3 or Cancer Among Women With Negative Cervical Cytology and Positive High-Risk Human Papillomavirus T...
• The Peru Cervical Cancer Prevention Study (PERCAPS): The technology to make screening accessible.
• Six-Year Regression and Progression of Cervical Lesions of Different Human Papillomavirus Viral Loads in Varied Histological Diagnoses.
• The Peru cervical Cancer prevention study (PERCAPS): community-based participatory research in Manchay, Peru.
• A New PCR-Based Mass Spectrometry System for High-Risk HPV, Part II: Clinical Trial.
• Population-based human papillomavirus 16,18, 6 and 11 DNA positivity and seropositivity in chinese women.
• Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing.
• A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II Study.
• Regardless of Skill, Performing More Biopsies Increases the Sensitivity of Colposcopy.
• Looking ahead: A case for HPV testing of self-sampled vaginal specimens as a cervical Cancer screening strategy.
• Diagnostic efficacy of computer extracted image features in optical coherence tomography of the preCancerous cervix.
• Human papillomavirus messenger RNA assay for cervical Cancer screening: the Shenzhen Cervical Cancer Screening Trial I.
• Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self...
• SNIPER: a novel assay for human papillomavirus testing among women in Guizhou, China.
• Role of the 18:1 lysophosphatidic acid-ovarian Cancer immunoreactive antigen domain containing 1 (OCIAD1)-integrin axis in generating late-stage ovarian Cancer.
• Study of the diagnostic efficacy of real-time optical coherence tomography as an adjunct to unaided visual inspection with acetic acid for the diagnosis of preinvasive...
• Diagnostic efficacy of real-time optical coherence tomography in the management of preinvasive and invasive neoplasia of the uterine cervix.
• Human papillomavirus testing for cervical Cancer screening: results from a 6-year prospective study in rural China.
• Concurrent cisplatin-based chemoradiation International Federation of Gynecology and Obstetrics stage IB2 cervical carcinoma.
• The Mexican Cervical Cancer Screening Trial: self-sampling for human papillomavirus with unaided visual inspection as a secondary screen.
• False negative colposcopy is associated with thinner cervical intraepithelial neoplasia 2 and 3.
• Letter to the editor concerning Petignat et al.'s "Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA te...
• Inappropriate gold standard bias in cervical Cancer screening studies.
• Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian Cancer by careful patient screening.
• Distribution of cervical intraepithelial neoplasia 2, 3 and Cancer on the uterine cervix.
• Inflation of sensitivity of cervical Cancer screening tests secondary to correlated error in colposcopy.
• Modern management of recurrent Ovarian carcinoma. A systematic approach to a chronic disease.
• Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse.
• A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.
• Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples.
• Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical Cancer: a pooled analysis of individual patient data from 17 population-base...
• CCL2 expression in primary Ovarian carcinoma is correlated with chemotherapy response and survival outcomes.
• Human papillomavirus DNA testing for cervical Cancer screening: practical aspects in developing countries.
• Are screen-and-treat approaches effective for cervical Cancer prevention?
• [Value of acetic acid smear test for cervical Cancer screening].
• Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions.
• Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.
• Shanxi Province cervical Cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid ba...
• Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, Fallopian tube cancer, and primary carcinoma of the peritoneum.
• Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, Fallopian tube, and primary peritoneal cancers.
• Experience with the management of neutropenia in gynecologic Cancer patients receiving carboplatin-based chemotherapy.
• Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian Cancer.
• Survival following the documentation of platinum and taxane resistance in ovarian Cancer: a single institution experience involving multiple phase 2 clinical trials.
• Examples of the marked variability in the relationship between the serum CA-125 antigen level and Cancer-related symptoms in ovarian Cancer.
• Diagnostic efficacy of optical coherence tomography in the management of preinvasive and invasive Cancer of uterine cervix and vulva.
• Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.
• Duration of response to second-line, platinum-based chemotherapy for ovarian Cancer: implications for patient management and clinical trial design.
• Phase 2 trial of carboplatin plus tamoxifen in platinum-resistant ovarian Cancer and primary carcinoma of the peritoneum.
• Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, Fallopian tube cancer, or primary carcinoma of the peritoneum.
• Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, Fallopian tube, and primary peritoneal cavity cancers.
• Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre'lat, a hint to the diagnosis of early stage ovarian Cancer: a case report and review of the liter...
• Phase 2 trial of prolonged administration of oral topotecan in platinum/taxane-refractory ovarian, Fallopian tube, and primary peritoneal cancers.
• Isolated cervical metastasis of breast Cancer: a case report and review of the literature.
• A rationale for neoadjuvant systemic treatment followed by surgical assessment and intraperitoneal chemotherapy in patients presenting with non-surgically resectable o...
• Optical diagnosis of cervical dysplasia.
• Risk factors for HPV infection and cervical Cancer among unscreened women in a high-risk rural area of China.
• Toxicity associated with carboplatin/paclitaxel/Irinotecan use in advanced ovarian Cancer: preliminary analysis.
• Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian Cancer.
• Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial Cancer.
• Carboplatin plus paclitaxel combination chemotherapy: impact of sequence of drug administration on treatment-induced neutropenia.
• Second-line therapy of ovarian Cancer with Paclitaxel administered by both the intravenous and intraperitoneal routes: rationale and case reports.
• Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial Ovarian tumors.
• Update on the diagnosis and treatment of human papillomavirus infection.
• Unfolding the pathophysiological role of bioactive lysophospholipids.
• Hypoxia enhances lysophosphatidic acid responsiveness in ovarian Cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
• Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive Cancer of the uterine cervix.
• Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
• Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian Cancer patients.
• Ovarian Cancer immuno-reactive antigen domain containing 1 (OCIAD1), a key player in ovarian Cancer cell adhesion.
• [Study on the correlation between human papillomavirus infection and cervical lesion among women living in community of Beijing].
• Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China.
• Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique.
• Mexican Cervical Cancer Screening Study II: acceptability of human papillomavirus self-sampler.
• Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian Cancers: a Gyne...
• Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial Cancer: surgical and survival outcomes.
• Paraaortic lymphadenectomy in gynecologic Cancer.
• Surgical management of Invasive carcinoma of the vulva utilizing a lower abdominal midline incision.
• Clear cell adenocarcinoma arising in endometriosis of the rectovaginal septum.
• Influence of exploratory celiotomy on the management of carcinoma of the cervix. A preliminary report.
• Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy.
• Squamous cell carcinoma of the cervix: HPV 16 and DNA ploidy as predictors of survival.
• Papillary serous adenocarcinoma of the endometrium: a clinicopathologic study of 19 cases.
• Palliative benefit of radiation therapy in advanced ovarian Cancer.
• Primary clear cell carcinoma of the peritoneum.
• Clinical stage I adenocarcinoma of the endometrium--analysis of recurrences and the potential benefit of staging lymphadenectomy.
• Recurrence in noninvasive endometrial carcinoma. Relationship to uterine papillary serous carcinoma.
• Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian Cancer.
• Management of epithelial Ovarian neoplasms using a platinum-based regimen: a 10-year experience.
• Serum albumin: its relationship to marrow and renal toxicity from platinum-based combination chemotherapy.
• Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.
• Glassy cell carcinoma of the endometrium responsive to megestrol acetate.

Schools

---

• University Of Missouri Columbia Campus

• Michael Reese Hospital and Med Center

• Colum Presby Hospital Med Center

• Sloan Hospital Women

• University Miami Jackson Meml Hospital

Conditions Treated

---

• Encounters for High-Risk Pregnancies
• Encounters for Normal Pregnancies
• Fallopian Tube Cancer
• Hyperlipidemia
• View All

Doctors Specialties

---

• Gynecologic Oncology
• Obstetrics
• Gynecology

Accepted Insurances

---

Awards

---

• The John L Lewis Presidential Award, 45th Annual Meeting on Women’s Cancer
• Friendship Award
• Chinese Friendship Award at the People’s Congress in Beijing – The Highest Award China gives to a Foreigner
• Awarded Best Presentation by a Fellow
• World Class Service Award for Patient Care, Department of Ob/GYN
• Citation of Merit, the highest given award, given annually to one alumnus to recognize that physician's contributions to the medical profession
• 3rd, 60-Meter Dash
• Paul Harris Fellow (for work in Mexico)
• Cited by Ladies Home Journal as one of the Top Doctors for Women in the United States, one of 15 Gynecologic Oncologists in the Northeast (13 states)
• Teacher of the Year, Dept. Ob/Gyn
• 1st Place Award ($5,000) Presentation at Eurogin
• Stewart Fellow (Humanitarianism in Medicine)
• 3rd, Long Jump
• 3rd Triple Jump
• 1st, Long Jump
• Cited in The Best Doctors in America, Midwest Region, Naifeh and Smith, 1st Ed
• 2nd, Long Jump
• Cited in The Best Doctors in America, Naifeh and Smith, 1st Ed
• Alpha Omega Alpha, Medical Honorary Society
• Teacher of the Year
• Certificate of Special Competence - Division of Gynecologic Oncology
• Fellow
• Fellow (FACOG)
• Cited several years as “top doctor”

Education

---

• Jackson Memorial Hospital - Jackson Health System
• New York Presbyterian Hospital - Columbia Campus
• University of Missouri-Columbia School of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Robert L. Debernardo Jr., MD
	Dr. Kristine M. Zanotti, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeffrey M. Mangel, MD This Doctor is OpenDoctor Recommended.
	Dr. Mostafa A. Selim, MD This Doctor is OpenDoctor Recommended.
	Dr. Peter G. Rose, MD
	Dr. Steven E. Waggoner, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan J. Lasch, MD This Doctor is OpenDoctor Recommended.
	Dr. Maureen M. Suster, MD This Doctor is OpenDoctor Recommended.
	Dr. Lori Weinberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Lara T. Hasan, MD
	Dr. Bogdan Orasanu, MD This Doctor is OpenDoctor Recommended.
	Dr. Shandhini Raidoo, MD This Doctor is OpenDoctor Recommended.
	Dr. Pearl N. Quartey, MD
	Dr. Jessica R. Woessner, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog